Provided by Tiger Trade Technology Pte. Ltd.

Neuronetics Inc.

1.46
-0.0300-2.01%
Post-market: 2.130.6700+45.89%17:58 EST
Volume:7.59M
Turnover:11.70M
Market Cap:99.99M
PE:-1.76
High:1.61
Open:1.52
Low:1.45
Close:1.49
52wk High:5.92
52wk Low:1.25
Shares:68.49M
Float Shares:43.21M
Volume Ratio:3.76
T/O Rate:17.55%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.8300
EPS(LYR):-1.3773
ROE:-218.99%
ROA:-21.21%
PB:3.66
PE(LYR):-1.06

Loading ...

Neuronetics Inc - Reports Q4 2025 Revenue of $41.8 Mln

THOMSON REUTERS
·
1 hour ago

Press Release: Neuronetics Announces Selected Preliminary Unaudited Fourth Quarter and Full Year 2025 Financial Results

Dow Jones
·
1 hour ago

Neuronetics Inc - on Jan 15, Entered Amendment No. 4 to Credit Agreement - SEC Filing

THOMSON REUTERS
·
Jan 22

Neuronetics Amends Credit Agreement With Perceptive Credit Holdings

Reuters
·
Jan 22

Neuronetics Awards Cash Bonuses and RSUs to Top Executives

Reuters
·
Jan 07

TAC-STIM Demonstrates Significant Performance Improvements in Active-Duty United States Air Force Airmen

GlobeNewswire
·
Dec 02, 2025

TRICARE West Expands NeuroStar® TMS Coverage to Include Adolescents Aged 15+ Struggling with Depression

GlobeNewswire
·
Nov 12, 2025

Neuronetics President, CEO Keith Sullivan to Retire

Dow Jones
·
Nov 04, 2025

Neuronetics Inc. Showcases Growth Strategy and Mental Health Solutions in Corporate Presentation

Reuters
·
Nov 04, 2025

Neuronetics Q3 revenue misses estimates

Reuters
·
Nov 04, 2025

Neuronetics Q3 EPS $(0.13) Misses $(0.10) Estimate, Sales $37.297M Miss $38.055M Estimate

Benzinga
·
Nov 04, 2025

BRIEF-Neuronetics Q3 Gross Margin 45.9%

Reuters
·
Nov 04, 2025

Neuronetics Inc - CEO Keith J. Sullivan to Retire June 2026

THOMSON REUTERS
·
Nov 04, 2025

Neuronetics Outlook Q4 Revenue USD 40-43 Million

THOMSON REUTERS
·
Nov 04, 2025

Neuronetics Reports Third Quarter 2025 Financial and Operating Results and Announces CEO Transition Plan

THOMSON REUTERS
·
Nov 04, 2025

Neuronetics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire
·
Nov 01, 2025

Neuronetics Inc expected to post a loss of 13 cents a share - Earnings Preview

Reuters
·
Oct 31, 2025

Neuronetics Inc - Partnership Pilot Launched in Q4 2025, Expansion Planned for 2026

THOMSON REUTERS
·
Oct 30, 2025

Neuronetics Announces Three-Year Exclusive Partnership with Elite DNA Behavioral Health to Expand NeuroStar Access and Operational Excellence

GlobeNewswire
·
Oct 30, 2025

Neuronetics Inc - Coverage Effective Oct 1 for Fee-for-Service Medicaid Members

THOMSON REUTERS
·
Sep 17, 2025